| Dr Greg Larry Perkins, MD | |
|
1214 South Grant Road, Mcfarland Clinic Pc, Carroll, IA 51401-3047 | |
| (712) 792-1500 | |
| (712) 792-7597 |
| Full Name | Dr Greg Larry Perkins |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 26 Years |
| Location | 1214 South Grant Road, Carroll, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164413605 | NPI | - | NPPES |
| 0273516 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 34825 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Anthony Home Health Agency | Carroll, IA | Home health agency |
| Carroll Area Nursing Services | Carroll, IA | Home health agency |
| Kindred Hospice | Carroll, IA | Hospice |
| Hospice Of The Midwest, Llc | Johnston, IA | Hospice |
| St Anthony Regional Hospice | Carroll, IA | Hospice |
| St Anthony Regional Hospital & Nursing Home | Carroll, IA | Hospital |
| Mary Greeley Medical Center | Ames, IA | Hospital |
| Regency Park Nursing & Rehab Center Of Carroll | Carroll, IA | Nursing home |
| Thomas Rest Haven | Coon rapids, IA | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mcfarland Clinic Pc | 1254244239 | 320 |
News Archive
BDI Pharma, Inc. (BDI), the fastest growing national distributor of biotech therapies, announced that revenue for the third quarter of 2009 continued to sustain the momentum experienced during the first two fiscal quarters of this year. A primary driver of third quarter revenue was the exceptional success of the company's expanded portfolio of specialty biotherapeutics.
Quebec Parkinson researchers receive a record $573,384 in funding from Parkinson Society Canada to increase their efforts to identify the causes of this degenerative brain disease for which there is currently no cure. At a Research Innovation event in Montreal this evening, hosted by Parkinson Society Quebec in partnership with McGill University and the CHUM, 11 Parkinson scientists will be lauded for their efforts in getting closer to a cure.
Techulon Inc., an early stage life sciences company has signed an agreement with Nacalai USA, Inc. and its parent company Nacalai Tesque, Inc. for distribution of its Glycofect Transfection Reagent platform products in Japan. Glycofect is a polymeric transfection reagent designed to be particularly effective in primary cells of therapeutic interest. It is being used by government, university and corporate laboratories around the world for advanced research towards better understanding of cell biology and for development of new cell-based therapeutics.
Researchers at the University of Toronto's Faculty of Medicine have developed the first antibody that detects the only known cause of amyotrophic lateral sclerosis (ALS), also called Lou Gehrig's disease.
Ohr Pharmaceutical, Inc. (OTCQB: OHRP), a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, today announced a 1-for-3 reverse split of the Company's issued and outstanding common stock. The reverse stock split will be effective prior to the stock market opening on Monday, June 3, 2013.
› Verified 1 days ago
| Entity Name | Mcfarland Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639135643 PECOS PAC ID: 1254244239 Enrollment ID: O20031106000338 |
News Archive
BDI Pharma, Inc. (BDI), the fastest growing national distributor of biotech therapies, announced that revenue for the third quarter of 2009 continued to sustain the momentum experienced during the first two fiscal quarters of this year. A primary driver of third quarter revenue was the exceptional success of the company's expanded portfolio of specialty biotherapeutics.
Quebec Parkinson researchers receive a record $573,384 in funding from Parkinson Society Canada to increase their efforts to identify the causes of this degenerative brain disease for which there is currently no cure. At a Research Innovation event in Montreal this evening, hosted by Parkinson Society Quebec in partnership with McGill University and the CHUM, 11 Parkinson scientists will be lauded for their efforts in getting closer to a cure.
Techulon Inc., an early stage life sciences company has signed an agreement with Nacalai USA, Inc. and its parent company Nacalai Tesque, Inc. for distribution of its Glycofect Transfection Reagent platform products in Japan. Glycofect is a polymeric transfection reagent designed to be particularly effective in primary cells of therapeutic interest. It is being used by government, university and corporate laboratories around the world for advanced research towards better understanding of cell biology and for development of new cell-based therapeutics.
Researchers at the University of Toronto's Faculty of Medicine have developed the first antibody that detects the only known cause of amyotrophic lateral sclerosis (ALS), also called Lou Gehrig's disease.
Ohr Pharmaceutical, Inc. (OTCQB: OHRP), a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, today announced a 1-for-3 reverse split of the Company's issued and outstanding common stock. The reverse stock split will be effective prior to the stock market opening on Monday, June 3, 2013.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Greg Larry Perkins, MD 1214 South Grant Road, Mcfarland Clinic Pc, Carroll, IA 51401-3047 Ph: (712) 792-1500 | Dr Greg Larry Perkins, MD 1214 South Grant Road, Mcfarland Clinic Pc, Carroll, IA 51401-3047 Ph: (712) 792-1500 |
News Archive
BDI Pharma, Inc. (BDI), the fastest growing national distributor of biotech therapies, announced that revenue for the third quarter of 2009 continued to sustain the momentum experienced during the first two fiscal quarters of this year. A primary driver of third quarter revenue was the exceptional success of the company's expanded portfolio of specialty biotherapeutics.
Quebec Parkinson researchers receive a record $573,384 in funding from Parkinson Society Canada to increase their efforts to identify the causes of this degenerative brain disease for which there is currently no cure. At a Research Innovation event in Montreal this evening, hosted by Parkinson Society Quebec in partnership with McGill University and the CHUM, 11 Parkinson scientists will be lauded for their efforts in getting closer to a cure.
Techulon Inc., an early stage life sciences company has signed an agreement with Nacalai USA, Inc. and its parent company Nacalai Tesque, Inc. for distribution of its Glycofect Transfection Reagent platform products in Japan. Glycofect is a polymeric transfection reagent designed to be particularly effective in primary cells of therapeutic interest. It is being used by government, university and corporate laboratories around the world for advanced research towards better understanding of cell biology and for development of new cell-based therapeutics.
Researchers at the University of Toronto's Faculty of Medicine have developed the first antibody that detects the only known cause of amyotrophic lateral sclerosis (ALS), also called Lou Gehrig's disease.
Ohr Pharmaceutical, Inc. (OTCQB: OHRP), a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, today announced a 1-for-3 reverse split of the Company's issued and outstanding common stock. The reverse stock split will be effective prior to the stock market opening on Monday, June 3, 2013.
› Verified 1 days ago
Dr. Michael John Slattery, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1214 South Grant Road, Mcfarland Clinic Pc, Carroll, IA 51401 Phone: 712-792-1500 Fax: 712-792-7597 | |
Dr. Julie Ann Perkins, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1214 South Grant Road, Mcfarland Clinic Pc, Carroll, IA 51401 Phone: 712-792-1500 Fax: 712-792-7597 | |
Linda Iler, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 515 N Main St, Carroll, IA 51401 Phone: 712-792-4000 Fax: 712-792-3554 | |
Dr. David Nystrom, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 405 S Clark St, Suite # 230, Carroll, IA 51401 Phone: 712-792-2222 Fax: 712-792-3875 | |
Michelle Lynn Heim, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1214 South Grant Road, Mcfarland Clinic Pc, Carroll, IA 51401 Phone: 712-792-1500 Fax: 712-792-7597 | |
Shaun Steven Quam, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1214 S Grant Rd, Carroll, IA 51401 Phone: 712-792-1500 Fax: 712-792-7597 |